Vasundhara Rasayans locks in new Dahej plant to replace expiring lease
The company secured a manufacturing agreement with its parent firm, PandJ Cretechem, to shift production to Gujarat and avoid downtime at its Mahad site.
What's new
- Vasundhara Rasayans signed a manufacturing deal with parent firm PandJ Cretechem for a facility in Dahej, Gujarat.
- The move resolves the operational risk of a lease termination at the company's existing Mahad plant.
- FY26 net profit rose to ₹5.78 cr from ₹4.24 cr; Ravi Jain joins the board as an independent director.
Why this matters
For a nano-cap company with a market cap of ₹39 crore, the loss of a manufacturing site is an existential threat. Securing a group-level agreement to shift production to a parent-owned facility provides a clear path to continuity that the market was likely pricing as a risk.
What we're watching
- The timeline for the physical transition of production from Mahad to Dahej.
- Whether the new manufacturing agreement impacts margins compared to the previous lease arrangement.
- Any further board changes following the retirement of the long-standing director.
The full read
Vasundhara Rasayans has resolved a looming operational crisis by securing a manufacturing agreement with its parent firm, PandJ Cretechem.
It was a necessary move.
The company will shift production of its pharmaceutical ingredients to a facility in Dahej, Gujarat, effectively neutralizing the risk posed by the upcoming lease termination at its Mahad plant. This transition is a critical stabilization for a company with a market capitalization of just ₹39 crore. Alongside the operational shift, the company reported FY26 net profits of ₹5.78 crore, up from ₹4.24 crore in the previous year, while simultaneously refreshing its governance structure by appointing Ravi Jain as an independent director and reconstituting its audit and remuneration committees. By formalizing support from its parent company, Vasundhara Rasayans has cleared the most immediate hurdle to its ongoing production, ensuring continuity as it enters the new fiscal year.
Questions answered
- Why is the move to the Dahej facility necessary?
- The company faces an upcoming lease termination at its current Mahad manufacturing unit. The new agreement with its parent company, PandJ Cretechem, allows it to shift production to Dahej and avoid potential downtime.
- How did the company perform financially in FY26?
- Vasundhara Rasayans reported a net profit of ₹5.78 crore for the year ended March 31, 2026. This is an increase from the ₹4.24 crore reported in the previous year.
- What changes were made to the board of directors?
- Ravi Jain was appointed as an independent director. The board also reconstituted its audit and remuneration committees following the retirement of a long-standing board member.
- What is the scale of the company?
- Vasundhara Rasayans is a nano-cap company with a market capitalization of approximately ₹39 crore.